Biocompatibility for medical devices - a scientific & regulatory imperative
Ensuring biocompatibility is a critical element of medical device development and regulatory compliance. At its core, biocompatibility means that a device — and the materials it is made from — interacts with the human body in a way that does not cause harmful biological responses during intended use. Under modern regulatory frameworks such as the EU Medical Device Regulation (MDR) and international standards like ISO 10993, a robust biocompatibility evaluation is not optional — it’s essential for product safety, market access, and confidence from reviewers and notified bodies.
Biocompatibility is not simply a checkbox in your medical device technical file. It is a science-driven assessment of biological risk that must be justified with evidence, appropriate documentation, and a clear understanding of how your device’s materials and design influence biological responses.
How we support your biocompatibility strategy
Ensuring biocompatibility is a fundamental part of developing safe and effective medical devices. It means that the materials and components of your device interact with the human body in a way that is biologically acceptable and supported by scientific evidence. In today’s regulatory environment — including expectations under EU Medical Device Regulation (MDR) and international standards such as ISO 10993 — a well-structured biocompatibility evaluation strengthens your technical documentation, supports conformity assessment and demonstrates a clear commitment to patient safety and risk management.
We specialize in two core deliverables: the Biological Evaluation Plan (BEP) and the Biological Evaluation Report (BER). These are comprehensive documents that explain, justify, and support your biological safety conclusions.